Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy ; volume:55 ; number:3 ; day:14 ; month:9 ; year:2015 ; pages:381-396 ; date:3.2016
Clinical pharmacokinetics ; 55, Heft 3 (14.9.2015), 381-396, 3.2016
- Urheber
-
Colbers, Angela
- Beteiligte Personen und Organisationen
-
Greupink, Rick
Litjens, Carlijn
Burger, David
Russel, Frans G. M.
SpringerLink (Online service)
- DOI
-
10.1007/s40262-015-0325-8
- URN
-
urn:nbn:de:1111-2016022233764
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Colbers, Angela
- Greupink, Rick
- Litjens, Carlijn
- Burger, David
- Russel, Frans G. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Physiologically Based Modelling Framework for Prediction of Pulmonary Pharmacokinetics of Antimicrobial Target Site Concentrations
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
Influence of ritonavir on the pharmacokinetics and pharmacodynamics of loperamide
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir
In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Safety and efficacy of lopinavir/ritonavir compared to nelfinavir-based HAART during pregnancy
Physiologically Based Modelling Framework for Prediction of Pulmonary Pharmacokinetics of Antimicrobial Target Site Concentrations
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
Influence of ritonavir on the pharmacokinetics and pharmacodynamics of loperamide
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir
In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Safety and efficacy of lopinavir/ritonavir compared to nelfinavir-based HAART during pregnancy
Physiologically Based Modelling Framework for Prediction of Pulmonary Pharmacokinetics of Antimicrobial Target Site Concentrations
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
Influence of ritonavir on the pharmacokinetics and pharmacodynamics of loperamide
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir
In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life